A citation-based method for searching scientific literature

Habib Yaribeygi, Ali Rashidy-Pour, Stephen L Atkin, Tannaz Jamialahmadi, Amirhossein Sahebkar. Life Sci 2021
Times Cited: 7







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Anti-inflammatory potentials of incretin-based therapies used in the management of diabetes.
Habib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar. Life Sci 2020
15
42

Incretin-based therapies and renin-angiotensin system: Looking for new therapeutic potentials in the diabetic milieu.
Habib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar. Life Sci 2020
5
40


Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes.
Antonio Ceriello, Anna Novials, Emilio Ortega, Silvia Canivell, Lucia La Sala, Gemma Pujadas, Katherine Esposito, Dario Giugliano, Stefano Genovese. Diabetes Care 2013
115
28

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.
Matthew J Armstrong, Diana Hull, Kathy Guo, Darren Barton, Jonathan M Hazlehurst, Laura L Gathercole, Maryam Nasiri, Jinglei Yu, Stephen C Gough, Philip N Newsome,[...]. J Hepatol 2016
180
28

Molecular mechanisms by which GLP-1 RA and DPP-4i induce insulin sensitivity.
Habib Yaribeygi, Thozhukat Sathyapalan, Amirhossein Sahebkar. Life Sci 2019
19
28

Neuromodulatory effects of anti-diabetes medications: A mechanistic review.
Habib Yaribeygi, Milad Ashrafizadeh, Neil C Henney, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar. Pharmacol Res 2020
9
28

Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases.
Maddalena Grieco, Alessandra Giorgi, Maria Cristina Gentile, Maria d'Erme, Susanna Morano, Bruno Maras, Tiziana Filardi. Front Neurosci 2019
46
28



Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled study.
J D Price, G Linder, W P Li, B Zimmermann, K I Rother, R Malek, M Alattar, K V Tarbell. Clin Exp Immunol 2013
22
28

Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control.
Young-Sun Lee, Hee-Sook Jun. Mediators Inflamm 2016
169
28


Antioxidative Potentials of Incretin-Based Medications: A Review of Molecular Mechanisms.
Habib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar. Oxid Med Cell Longev 2021
3
66



Liraglutide improves cognitive impairment via the AMPK and PI3K/Akt signaling pathways in type 2 diabetic rats.
Ying Yang, Hui Fang, Gang Xu, Yanfeng Zhen, Yazhong Zhang, Jinli Tian, Dandan Zhang, Guyue Zhang, Jing Xu. Mol Med Rep 2018
27
28


GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.
Hari Hendarto, Toyoshi Inoguchi, Yasutaka Maeda, Noriko Ikeda, Jing Zheng, Ryoko Takei, Hisashi Yokomizo, Eiichi Hirata, Noriyuki Sonoda, Ryoichi Takayanagi. Metabolism 2012
142
14

Antioxidative potential of antidiabetic agents: A possible protective mechanism against vascular complications in diabetic patients.
Habib Yaribeygi, Alexandra E Butler, George E Barreto, Amirhossein Sahebkar. J Cell Physiol 2019
34
14

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.
Xiaokun Ding, Neeraj K Saxena, Songbai Lin, Nitika Arora Gupta, Frank A Anania. Hepatology 2006
386
14

Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus.
Kenta Okada, Kazuhiko Kotani, Hiroaki Yagyu, Akihiko Ando, Jun-Ichi Osuga, Shun Ishibashi. Endocrine 2014
19
14

Crocin potentiates antioxidant defense system and improves oxidative damage in liver tissue in diabetic rats.
Habib Yaribeygi, Mohammad Taghi Mohammadi, Amirhossein Sahebkar. Biomed Pharmacother 2018
34
14

Glucagon-like peptide-1 receptor agonist stimulates mitochondrial bioenergetics in human adipocytes.
Joanna Góralska, Agnieszka Śliwa, Anna Gruca, Urszula Raźny, Monika Chojnacka, Anna Polus, Bogdan Solnica, Małgorzata Malczewska-Malec. Acta Biochim Pol 2017
13
14


Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes.
Supachoke Mangmool, Piriya Hemplueksa, Warisara Parichatikanond, Nipon Chattipakorn. Mol Endocrinol 2015
30
14

DPP-4 inhibitors.
Bo Ahrén. Best Pract Res Clin Endocrinol Metab 2007
119
14

SIRT1/HSF1/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress.
Xiaobin Zheng, Fen Xu, Hua Liang, Huanyi Cao, Mengyin Cai, Wen Xu, Jianping Weng. Hepatology 2017
39
14

Glucagon-like peptide-1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARα pathway.
Lujin Wu, Ke Wang, Wei Wang, Zheng Wen, Peihua Wang, Lei Liu, Dao Wen Wang. Aging Cell 2018
34
14

Oxidative stress and diabetic complications.
Ferdinando Giacco, Michael Brownlee. Circ Res 2010
14

Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages.
Łukasz Bułdak, Krzysztof Łabuzek, Rafał Jakub Bułdak, Grzegorz Machnik, Aleksandra Bołdys, Bogusław Okopień. Naunyn Schmiedebergs Arch Pharmacol 2015
20
14

Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits.
Xiaowei Zhang, Zhiwei Zhang, Yungang Zhao, Ning Jiang, Jiuchun Qiu, Yajuan Yang, Jian Li, Xue Liang, Xinghua Wang, Gary Tse,[...]. J Am Heart Assoc 2017
35
14

EX4 stabilizes and activates Nrf2 via PKCδ, contributing to the prevention of oxidative stress-induced pancreatic beta cell damage.
Mi-Hwi Kim, Eung-Hwi Kim, Hye Seung Jung, Dongki Yang, Eun-Young Park, Hee-Sook Jun. Toxicol Appl Pharmacol 2017
29
14

Protective effect of recombinant human glucagon-like peptide-1 (rhGLP-1) pretreatment in STZ-induced diabetic mice.
Ye-Lin Wu, Jing Huang, Jian Liu, Ming-Fei Jin, Mei Gu, Yiguo Hong, Zi-Rong Wu. J Pept Sci 2011
12
14

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
14

The Underlying Role of Oxidative Stress in Neurodegeneration: A Mechanistic Review.
Habib Yaribeygi, Yunes Panahi, Behjat Javadi, Amirhossein Sahebkar. CNS Neurol Disord Drug Targets 2018
52
14

Dietary Modulation of Oxidative Stress in Alzheimer's Disease.
Arjun Thapa, Nick J Carroll. Int J Mol Sci 2017
37
14

Role of nrf2 in oxidative stress and toxicity.
Qiang Ma. Annu Rev Pharmacol Toxicol 2013
14

Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation.
Shunsuke Kubota, Yoko Ozawa, Toshihide Kurihara, Mariko Sasaki, Kenya Yuki, Seiji Miyake, Kousuke Noda, Susumu Ishida, Kazuo Tsubota. Invest Ophthalmol Vis Sci 2011
78
14

Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects.
Wathik Alsalim, Olga Göransson, Richard D Carr, Roberto Bizzotto, Andrea Tura, Giovanni Pacini, Andrea Mari, Bo Ahrén. Diabetes Obes Metab 2018
9
14

Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy.
Juan F Navarro-González, Carmen Mora-Fernández, Mercedes Muros de Fuentes, Javier García-Pérez. Nat Rev Nephrol 2011
577
14


Antidiabetic potential of saffron and its active constituents.
Habib Yaribeygi, Vahid Zare, Alexandra E Butler, George E Barreto, Amirhossein Sahebkar. J Cell Physiol 2019
17
14

Glucagon-like peptide-1 counteracts oxidative stress-dependent apoptosis of human cardiac progenitor cells by inhibiting the activation of the c-Jun N-terminal protein kinase signaling pathway.
L Laviola, A Leonardini, M Melchiorre, M R Orlando, A Peschechera, A Bortone, D Paparella, A Natalicchio, S Perrini, F Giorgino. Endocrinology 2012
26
14

Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study.
Manfredi Rizzo, Nicola Abate, Manisha Chandalia, Ali A Rizvi, Rosaria V Giglio, Dragana Nikolic, Antonella Marino Gammazza, Ignazio Barbagallo, Esma R Isenovic, Maciej Banach,[...]. J Clin Endocrinol Metab 2015
57
14

Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells.
Jui-Ting Chang, Yao-Jen Liang, Chia-Yu Hsu, Chao-Yi Chen, Po-Jung Chen, Yi-Feng Yang, Yen-Lin Chen, Dee Pei, Jin-Biou Chang, Jyh-Gang Leu. BMC Pharmacol Toxicol 2017
17
14


Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction.
Shinichi Someya, Wei Yu, William C Hallows, Jinze Xu, James M Vann, Christiaan Leeuwenburgh, Masaru Tanokura, John M Denu, Tomas A Prolla. Cell 2010
748
14

Liraglutide Activates the Nrf2/HO-1 Antioxidant Pathway and Protects Brain Nerve Cells against Cerebral Ischemia in Diabetic Rats.
Caihong Deng, Jun Cao, Jiangquan Han, Jianguo Li, Zhaohun Li, Ninghua Shi, Jing He. Comput Intell Neurosci 2018
23
14

Are sirtuins viable targets for improving healthspan and lifespan?
Joseph A Baur, Zoltan Ungvari, Robin K Minor, David G Le Couteur, Rafael de Cabo. Nat Rev Drug Discov 2012
278
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.